
Current Challenges and Management of Diseases in the Elderly Population
Beschreibung
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
Weitere Details
Weitere Ausgaben
Inhalt
- Intro
- Contents
- Foreword
- References
- Preface
- References
- Chapter 1
- Stem Cell Aging: An Epigenetic Perspective
- Abstract
- 1. Introduction
- 2. Epigenetic Regulation of Stem Cell Fate Decision and Aging
- 2.1. DNA Methylation/Demethylation in Stem Cell Fate Decision and Aging
- 2.2. Histone Modifications in Stem Cell Fate Decision
- 2.3. Role of Histone Modifications in Stem Cell Aging
- 2.3.1. Role of Histone Modifications in Mesenchymal Stem Cells (MSCs) Aging
- 2.3.2. Role of Histone Modifications in Muscle Stem Cells (MuSCs) and Other Stem Cells Aging
- 2.4. Epigenetic Crosstalk between DNA Methylation and Histone Modifications in Aging Stem Cells
- 2.5. Role of Small Non-coding RNAs in Stem Cell Fate Decision and Aging
- 2.5.1. Role of Micro RNAs in Hematopoietic Stem Cell (HSCs) Aging
- 2.5.2. Role of Micro RNAs in Mesenchymal Stem Cell (MSCs) Aging
- 2.5.3. Role of Micro RNAs in Muscle Stem Cells (MuSCs) and other Stem Cell Aging
- 3. Aging Stem Cell Epigenome and Diseases
- References
- Chapter 2
- Failure of Optimum Activation in Aged T Cells Compromises Their Response to Antigens
- Abstract
- 1. Introduction
- 2. Activation of T Cells
- 3. Prerequisite for T Cell Activation
- 4. Expression of Costimulatory Molecules
- 5. Expression of Cytokine for T Cell Activation
- 6. TCR Signaling in T Cell Activation
- 7. Proliferation
- 8. T Cell Activation vs T Cell Effector Response
- 9. Altered Function of Aged CD4+ T Cells
- 10. Altered Function of Aged CD8+ T Cells
- 11. Altered Function of Aged Regulatory T Cells
- 12. Cytolytic Response
- 13. Failure of Activation in Aged T Cells
- 14. Outcome of Impaired T Cell Activation in Aged T Cells
- 14.1. Immune Response to Vaccine
- 14.2. Compromised Response to Infections
- 14.3. Occurrence of Solid Tumors and Hematological Malignancies
- 15. Approaches to Overcome The Failed T Cell Activation in Aged T Cells
- References
- Chapter 3
- Diabetes, Neuropathy in Elderly Population
- Abstract
- 1. Introduction
- 2. Pathogenic Mechanisms
- 2.1. Polyol Pathway Hyperactivity and Oxidative Stress
- 2.2. Microvascular Changes
- 2.3. Channels Sprouting
- 2.4. Microglial Activation
- 2.5. Central Sensitization
- 2.6. Inflammation
- 3. Clinical Presentation
- 3.1. Focal Mononeuropathies
- 3.2. Diffuse Neuropathies
- 3.2.1. Proximal Motor Neuropathies/Diabetic Amyotrophy
- 3.2.2. Diabetes Autonomic Neuropathy
- 3.2.3. Distal Sensorimotor Polyneuropathy (DPN)
- 3.2.3.1. Large Fibre Neuropathies
- 3.2.3.2. Small Fibre Neuropathies
- 3.3. Charcot Neuroarthropathy
- 4. Differential Diagnosis and Diagnosis
- 5. Management of Neuropathy
- 5.1. Targeting the Pathogenic Mechanisms
- 5.2. Therapy Aimed at Treating Symptoms in Patients with DPN
- 6. Special Consideration
- Conclusion
- References
- Chapter 4
- Bone Diseases in Elderly Population: Challenges and Management
- Abstract
- Introduction
- Types of Bone Diseases
- Osteoporosis
- Paget's Disease
- Osteoarthritis and Rheumatoid Arthritis
- Osteomalacia
- Aging and Bone Loss
- Treatment and Management of Bone Diseases
- Osteoporosis
- Paget's Disease
- Rheumatoid Arthritis
- Conclusion and Future Perspective
- References
- Chapter 5
- Osteoporosis in Female: Strategies for Prevention, Promotion, and Restoration of Bone Health
- Abstract
- 1. Introduction
- 2. Classification of Osteoporosis
- 3. Bone Metabolism
- 3.1. Modeling and Remodeling of Bone
- 4. Genetic Factors
- 5. Major Osteoporotic Fractures
- 5.1. Hip Fracture
- 5.2. Spinal Fractures
- 5.3. Fractures of Wrist
- 6. FRAX in Fracture Prediction
- 7. Osteoporosis: Diagnosis and Tests
- 8. Life Style and Bone Health
- 8.1. Exercises and Bone Health
- 8.2. Benefits of Exercises in Bone Health!
- 9. Fall Prevention
- 10. Nutrition and Bone Health
- 10.1. List of Calcium Rich Eatables
- 11. Postmenopausal Osteoporosis
- 12. Vitamin D Deficiency
- 12.1. Vitamin D Deficiency and Secondary Hyperparathyroidism
- 13. Conclusion
- 14. Key Message
- Acknowledgments
- References
- Chapter 6
- Aging Eye: An Insight to Common Vision Problems and Associated Challenges
- Abstract
- 1. Introduction
- 2. Ageing-Related Eye Problems
- 2.1. Age-Related Macular Degeneration
- 2.2. Cataract
- 2.3. Glaucoma
- 2.4. Diabetic Retinopathy
- 2.5. Dry Eyes
- 3. Preventive Measures
- Acknowledgments
- References
- Chapter 7
- Metabolomics: Towards Health Care Challenges and Management in Elderly Population
- Abstract
- 1. Introduction
- 2. What Is Metabolomics and Metabonomics?
- 2.1. Various Analytical Techniques for Metabolomics
- 2.1.1. Mass Spectroscopy
- 2.1.2. Gas Chromatography-mass Spectrometry (GC-MS)
- 2.1.3. Liquid Chromatography-mass Spectrometry (LC-MS)
- 2.1.4. Capillary Electrophoresis-Mass Spectrometry (CE-MS)
- 2.1.5. Ion Mobility Mass Spectrometry
- 2.1.6. Fourier Transform-infrared Spectroscopy (FT-IR)
- 2.1.7. MALDI-ToFMS
- 2.1.8. Nuclear Magnetic Resonance (NMR) Spectroscopy
- 2.1.9. Hyphenated Techniques
- 2.2. Metabolomics Workflow
- 3. Application of Metabonomics
- 3.1. Identification of Biomarkers
- 3.2. Herbal Medicine
- 3.3. Determination of Disease State
- 3.4. Drug Discovery and Disease Diagnostics
- 4. Role of Metabonomics in Disease Diagnosis in Elderly Population
- 4.1. Dementia
- 4.2. Parkinson's Disease (PD)
- 4.3. Inflammatory Bowel Disease (IBD)
- 4.4. Arthritis
- 4.5. Depression
- 4.6. Diabetes
- 4.7. Inborn Errors of Metabolism
- 4.8. Sclerosis
- 5. Metabolomics as Ageing Biomarker
- 6. 'OMICS': Integrated Approach as Potential Solution in Ageing Research
- Conclusion
- References
- Chapter 8
- Advancement in Biomarkers Discovery for Elderly Population
- Abstract
- 1. Introduction
- 1.1. 'Omics' Approach for Biomarker Discovery in Elderly Population
- 2. The 'OMICS' Technology
- 2.1. Genomics
- 2.1.1. Tools to Study Genomics
- 2.1.1.1. DNA Microarrays
- 2.1.1.2. Next Generation Sequencing (NGS)
- 2.2. Transcriptomics
- 2.2.1. Tools to Study Transcriptomics
- 2.2.1. Microarray Technology
- 2.2.2. RNA Sequencing (RNA-Seq)
- 2.2.2.1. Advantages of RNA-Seq
- 2.3. Proteomics
- 2.3.1. Tools to Study Proteomics
- 2.3.1.1. Protein Profiling and Analyses Tools
- Enzyme Linked Immunosorbent Assay (ELISA)
- Western Blotting
- Protein Microarrays
- 2.3.1.2. Protein Quantification Tools
- Gel-Based Methods
- Gel-Free Methods
- 2.3.1.3 Protein Sequencing Analysis Tool
- Mass Spectrometry
- 2.4. Metabolomics
- 2.4.1. NMR Spectroscopy
- 2.4.2. Mass Spectrometry
- 2.4.3. Bioinformatics Tools
- 3. Medical Non-Invasive Tools
- 3.1. Positron-Emission Tomography (PET- SCAN)
- 3.2. Magnetic Resonance Imaging (MRI-SCAN)
- 3.3. Electrocardiogram (ECG)
- 4. Omics Research in Biomarker Discovery for Elderly Population
- 4.1. Normal Ageing
- 4.2. Parkinson's Disease
- 4.3. Alzheimer's Disease
- 4.4. Cardiac Diseases
- 4.5. Osteoarthritis (OA)
- Conclusion
- References
- Chapter 9
- The Role of Natural Polyphenols on Neurodegenerative Disorders
- Abstract
- 1. Introduction
- 2. Types of Neurodegeneration
- 2.1. Alzheimer's Disease
- 2.2. Parkinson's Disease
- 2.3. Huntington's Disease
- 3. Causes and Symptoms
- 4. Molecular Mechanism and Signalling
- 4.1. mTOR Signalling in Neurodegeneration
- 4.2. AMPK Dysregulation
- 5. Oxidative Stress and Neurodegeneration
- 6. Apoptosis
- 7. Therapeutic Interventions
- 8. Therapeutic Intervention Involving Polyphenols
- Concluding Remarks and Perspectives
- Acknowledgments
- References
- Chapter 10
- Role of Diet and Nutrition in Brain Health
- Abstract
- 1. Introduction
- 2. Ageing as a Science
- 3. Nutrition in Older Adults
- 3.1. As a Preventive Aspect of Treatment, Nutritional and Dietary Care is Majorly of Three Types
- 4. Brain
- 5. Brain Health
- 6. Nutrition in Brain Health
- 6.1. Lipids
- 6.2. Proteins
- 6.3. Carbohydrate
- 6.4. Vitamins
- 6.4.1. Vitamin B1 (Thiamine)
- 6.4.2. Vitamin B3 (Niacin)
- 6.4.3. Vitamin B6 (Pyridoxine)
- 6.4.4. Vitamin B9 (Folic Acid/Folate)
- 6.4.5. Vitamin B12 (Cobalamin)
- 6.4.6. Vitamin C (Citric Acid)
- 6.4.7. Vitamin D (Cholecaliferol)
- 6.4.8. Vitamin E
- 6.5. Minerals
- 6.5.1. Calcium
- 6.5.2. Zinc
- 6.5.3. Iron
- 6.5.4. Magnesium
- 6.5.5. Sodium
- 7. Diet in Brain Health
- 7.1. Mediterranean Diet
- 7.1.1. Do Not Eat Foods
- 7.2. DASH Diet
- 7.3. MIND Diet
- Conclusion
- References
- Websites
- About the Editor
- Index
- Blank Page
Systemvoraussetzungen
Dateiformat: PDF
Kopierschutz: Adobe-DRM (Digital Rights Management)
Systemvoraussetzungen:
- Computer (Windows; MacOS X; Linux): Installieren Sie bereits vor dem Download die kostenlose Software Adobe Digital Editions (siehe E-Book Hilfe).
- Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions oder die App PocketBook (siehe E-Book Hilfe).
- E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)
Das Dateiformat PDF zeigt auf jeder Hardware eine Buchseite stets identisch an. Daher ist eine PDF auch für ein komplexes Layout geeignet, wie es bei Lehr- und Fachbüchern verwendet wird (Bilder, Tabellen, Spalten, Fußnoten). Bei kleinen Displays von E-Readern oder Smartphones sind PDF leider eher nervig, weil zu viel Scrollen notwendig ist.
Mit Adobe-DRM wird hier ein „harter” Kopierschutz verwendet. Wenn die notwendigen Voraussetzungen nicht vorliegen, können Sie das E-Book leider nicht öffnen. Daher müssen Sie bereits vor dem Download Ihre Lese-Hardware vorbereiten.
Bitte beachten Sie: Wir empfehlen Ihnen unbedingt nach Installation der Lese-Software diese mit Ihrer persönlichen Adobe-ID zu autorisieren!
Weitere Informationen finden Sie in unserer E-Book Hilfe.